Xylyx Bio, Inc.

Our collaboration with Dr. Zeynep Madak-Erdogan's team at the University of Illinois has revealed differential responses to a drug in metastatic sites using our IN SITE™ Metastasis Kit.

https://www.prnewswire.com/news-releases/xylyx-bio-collaboration-reveals-new-insights-into-tumor-drug-resistance-301517042.html?tc=eml_cleartime

Xylyx Bio collaboration reveals new insights into tumor drug resistance /PRNewswire/ -- Xylyx Bio develops physiologic disease models that enable researchers to gain insights into tumor biology and evaluate the efficacy of drug...

Seeking alternatives to ? Stock up with 20% off of TissueSpec® ECM Hydrogel kits using the promotional code: TISSUESPEC2021

Xylyx Bio, Inc. extracellular matrix hydrogels are specific to bone, intestine, liver, lung, and other tissues with minimal lot-to-lot variability and are compatible with conventional and advanced cell culture techniques!

Visit our virtual booth at this year's Antifibrotic Drug Development Summit.

https://afdd-summit.com/xylyx-bio-virtual-booth/

It's now easier to send Xylyx Bio, Inc. a message.

Join us on November 2 to learn about how our IN MATRICO platform can revolutionize anti-fibrotic drug discovery.

And visit our virtual booth at this years Antifibrotic Drug Development Summit: https://afdd-summit.com/xylyx-bio-virtual-booth/

Xylyx Bio Awarded $2.2M NIH SBIR Fast-Track Grant from NHLBI.

Read more here: https://www.prnewswire.com/news-releases/xylyx-bio-awarded-2-2m-nih-sbir-fast-track-grant-from-national-heart-lung-and-blood-institute-301367888.html?tc=eml_cleartime

Xylyx Bio Awarded $2.2M NIH SBIR Fast-Track Grant from National Heart, Lung, and Blood Institute /PRNewswire/ -- Xylyx Bio, Inc., a biotechnology company developing groundbreaking solutions for drug discovery and tissue modeling and repair, announced today...

Xylyx Bio is excited to announce a partnership with to develop tissue-specific, digitally-printed bioinks for drug discovery.

Learn more here: https://www.prnewswire.com/news-releases/xylyx-bio-partners-with-inventia-life-science-to-develop-tissue-specific-digitally-printed-bioinks-for-drug-discovery-301366587.html?tc=eml_cleartime

Xylyx Bio partners with Inventia Life Science to develop tissue-specific, digitally-printed bioinks for drug discovery /PRNewswire/ -- Xylyx Bio, a New York-based leader in advanced biomaterials, and Inventia Life Science, a Sydney-based biotechnology company, today announced...

Interested in learning more about cell culture media? Take a moment to read this recent blogpost where our Senior Research Scientist, Evelyn Aranda, provides her view on how to choose the right for your .

https://www.genengnews.com/topics/bioprocessing/3d-cell-culture-media-secret-sauce-for-success/

3D Cell Culture Media: Secret Sauce for Success The major difference between ordinary 2D or suspension cultures and 3D is the extracellular matrix, which holds the cells together and confers biological relevance.

Assay provides a human fibrotic lung testing environment for , and .
Learn more about our services offerings here: https://xylyxbio.com/in-matrico-compound-testing-services/

Primary human hepatocytes cultured in thin hydrogels showed significantly higher expression of LDL receptor in ® Liver compared to cultured in .
Learn more about our liver ECM offerings here: https://shop.xylyxbio.com/products/liver

Primary normal human bronchial epithelial cells in
® formed more organized, stratified luminal structures recapitulating the cellular
architecture of the human airway compared to .
Learn more about our products here: https://xylyxbio.com/products/

Tune in today to learn more about our substrates and their use in .

® Skin induces cell migration:
A375 cells show significantly different migration through transwell membrane (pores: 8 μm) to TissueSpec® Skin ECM Hydrogel in comparison to Matrigel and plastic (no ECM).

cells (a) BT-549 and (b) T47-D in ® Bone, Liver, and Lung show differential responses in viability to or vehicle after 48 hours.

® supports phenotype:
Primary human cultured in TissueSpec® Bone ECM Hydrogel show characteristic dendritic morphology after 1 hour in culture. Osteoblasts have higher alkaline phosphatase activity in TissueSpec® Bone ECM Hydrogel than in Matrigel and collagen I after 7 days in culture.
Learn more here:https://xylyxbio.com/wp-content/uploads/2020/04/Xylyx_TissueSpec%C2%AE-Bone-ECM-Hydrogel-Product-Datasheet.pdf

Meet our CSO John O'Neill at the poster session on April 22nd!

JAB Maui Burn & Wound Symposium Agenda The JAB Maui Burn & Wound Symposium is an international conference that covers the latest advancements in wound healing, burn care, and infection control. Presentations are made by physicians, nurs...

https://www.cosmeticsdesign.com/Article/2021/04/08/ECM-specialists-Xylyx-Bio-launch-skin-care-brand-VIVIQ

ECM specialists Xylyx Bio launch skin care brand Today, executives from Xylyx Bio announced the launch of VIVIQ Skin Health, a consumer brand that leverages proprietary ECM tech.

We would like to share some exciting news! We have officially launched our brand VIVIQ Skin Health! Based on our ® Biotechnology, it is designed to bring clinic-worthy results to .
Please visit the website https://viviqskin.com/ to get a special promo!
https://www.prnewswire.com/news-releases/viviq-skin-health-launches-to-bring-clinical-benefits-to-prestige-skincare-301264643.html?tc=eml_cleartime

VIVIQ™ Skin Health Launches to Bring Clinical Benefits to Prestige Skincare /PRNewswire/ -- VIVIQ Skin Health, a prestige skincare brand, launched today with the world's first and only skincare product powered by Matrikynes®...

Our products were highlighted in today's editorial by on the importance of extracellular matrix in 3D cell culture!

Extracellular Matrix: The Secret Sauce of 3D Cell Culture ECM is the framework on which many advanced 3D cultures are built.